Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRBP Corbus Pharmaceuticals

Pre-Mkt 07-23 07:16:30 EDT

8.84

-0.14

-1.56%

盘前8.74

-0.10-1.09%

04:11 EDT

High9.10	Low8.73	Vol154.54K
Open8.97	D1 Closing8.98	Amplitude4.12%
Mkt Cap163.79M	Tradable Cap146.51M	Total Shares18.53M
T/O1.36M	T/O Rate0.93%	Tradable Shares16.57M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals","latestPrice":8.84,"timestamp":1784750400000,"preClose":8.98,"halted":0,"volume":154538,"hourTrading":{"tag":"盘前","latestPrice":8.7437,"preClose":8.84,"latestTime":"04:11 EDT","volume":77,"amount":673.2649,"timestamp":1784794317721,"change":-0.0963,"changeRate":-0.010894,"amplitude":0},"delay":0,"changeRate":-0.015590200445434362,"floatShares":16573985,"shares":18527795,"eps":-5.660431,"marketStatus":"Pre-Mkt","change":-0.14,"latestTime":"07-23 07:16:30 EDT","open":8.97,"high":9.1,"low":8.73,"amount":1362560.77331,"amplitude":0.041203,"askPrice":9.5,"askSize":50,"bidPrice":8,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-5.660431,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784813400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":8.84,"preHourTrading":{"tag":"盘前","latestPrice":8.7437,"preClose":8.84,"latestTime":"04:11 EDT","volume":77,"amount":673.2649,"timestamp":1784794317721,"change":-0.0963,"changeRate":-0.010894,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":8.7417,"preClose":8.84,"latestTime":"19:55 EDT","volume":1156,"amount":10185.3147,"timestamp":1784764530480,"change":-0.0983,"changeRate":-0.01112,"amplitude":0.015837},"volumeRatio":0.757887695792422,"impliedVol":1.1055,"impliedVolPercentile":0.608},"requestUrl":"/m/hq/s/CRBP","defaultTab":"news","newsList":[{"id":"2653796755","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2653796755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653796755?lang=en_us&edition=fundamental","pubTime":"2026-07-23 05:19","pubTimestamp":1784755140,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 1.56% to $8.84 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.57% to 25,690.90 and Dow Jones Industrial Average  falling 0.01% to 52,218.58.Corbus Pharmaceuticals Holdings Inc. closed 57.00% below its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  fell 2.37% to $5.35, Fortress Biotech Inc.  rose 0.57% to $3.55, and Viking Therapeutics Inc.  fell 1.69% to $37.31.Trading volume  remained 377,496 below its 50-day average volume of 531,981.Data source: Dow Jones Market Data, FactSet. Data compiled July 22, 2026.This co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249882","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249882","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249882?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:21","pubTimestamp":1784582460,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 1.33% to $8.89 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.05% to 25,508.07 and Dow Jones Industrial Average  falling 0.59% to 51,839.26.Corbus Pharmaceuticals Holdings Inc. closed 56.76% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  fell 2.21% to $5.32, Fortress Biotech Inc.  fell 0.89% to $3.33, and Viking Therapeutics Inc.  fell 1.89% to $36.38.Trading volume  remained 334,726 below its 50-day average volume of 544,275.Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.This content ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652708238","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2652708238","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652708238?lang=en_us&edition=fundamental","pubTime":"2026-07-18 05:20","pubTimestamp":1784323200,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 2.39% to $9.01 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.40% to 25,520.24 and Dow Jones Industrial Average  falling 0.77% to 52,146.42.The stock's rise snapped a four-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 56.18% below its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its competitors Friday, as Vanda Pharmaceuticals Inc.  fell 0.18% to $5.44, Fortress Biotech Inc.  fell 1.75% to $3.36, and Viking Therapeutics Inc.  rose 1.95% to $37.08.Trading volume  remained 329,911 below its 50-day average volume of 544,654.Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.This con","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652427143","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2652427143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652427143?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:19","pubTimestamp":1784236740,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 2.33% to $8.80 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index  falling 1.47% to 25,881.95 and Dow Jones Industrial Average  falling 0.20% to 52,552.97.This was the stock's fourth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 57.20% short of its 52-week high of $20.56, which the company achieved on October 20th.Despite its losses, the stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 6.84% to $5.45, Fortress Biotech Inc.  fell 7.82% to $3.42, and Viking Therapeutics Inc.  fell 3.81% to $36.37.Trading volume  remained 316,931 below its 50-day average volume of 545,721.Data source: Dow Jones Market Data, FactS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651443561","title":"Corbus Pharmaceuticals Holdings Inc. Stock Slides 6.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2651443561","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651443561?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:33","pubTimestamp":1783974780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. slid 6.6% to $9.04 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.6% to 25,873.18 and Dow Jones Industrial Average falling 0.3% to 52,498.64.The stock's fall snapped a four-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 56.0% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 3.8% to $6.00, Fortress Biotech Inc. remained unchanged, and Viking Therapeutics Inc. fell 1.90% to $38.12.Trading volume totaled 362,228, compared to the 50-day average of 550,920.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 13, 2026 16:33 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650972226","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2650972226","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650972226?lang=en_us&edition=fundamental","pubTime":"2026-07-10 05:18","pubTimestamp":1783631880,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms MarketThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 1.15% to $9.66 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 1.30% to 26,206.89 and the Dow Jones Industrial Average  rising 0.27% to 52,487.41.This was the stock's third consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 53.02% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 3.04% to $6.38, Fortress Biotech Inc.  rose 9.67% to $3.29, and Viking Therapeutics Inc.  rose 2.95% to $41.14.Trading volume  remained 325,157 below its 50-day average volume of 555,333.Data source: Dow Jones Market Da","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650557919","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2650557919","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650557919?lang=en_us&edition=fundamental","pubTime":"2026-07-09 05:17","pubTimestamp":1783545420,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 1.81% to $9.55 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.20% to 25,870.65 and the Dow Jones Industrial Average  falling 1.09% to 52,348.39.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 53.55% short of its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  rose 2.97% to $6.58, Fortress Biotech Inc.  rose 0.33% to $3.00, and Viking Therapeutics Inc.  fell 5.15% to $39.96.Trading volume  remained 59,510 below its 50-day average volume of 550,373.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649674876","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2649674876","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649674876?lang=en_us&edition=fundamental","pubTime":"2026-07-07 05:20","pubTimestamp":1783372800,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 2.70% to $9.00 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.12% to 26,121.16 and the Dow Jones Industrial Average  rising 0.29% to 53,055.91.Corbus Pharmaceuticals Holdings Inc. closed 56.23% short of its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 0.32% to $6.23, Fortress Biotech Inc.  fell 2.96% to $2.95, and Viking Therapeutics Inc.  rose 3.39% to $38.71.Trading volume  remained 283,482 below its 50-day average volume of 546,221.Data source: Dow Jones Market Data, FactSet. Data compiled July 6, 2026.This cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649262992","title":"Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.d. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2649262992","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649262992?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:00","pubTimestamp":1783339203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUABFQ2DH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649062991","title":"Press Release: Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2649062991","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649062991?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:00","pubTimestamp":1783339200,"startTime":"0","endTime":"0","summary":"NORWOOD, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (\"Corbus\" or the \"Company\"), a clinical-stage company focused on developing promising new therapi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","NETL","ADC","R","BK4232","CRBP","BK4080","BK4022","BK4139","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648521875","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2648521875","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648521875?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:19","pubTimestamp":1782940740,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 3.30% to $9.07 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.66% to 26,040.03 and Dow Jones Industrial Average  falling 0.03% to 52,305.24.The stock's fall snapped a four-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 55.89% short of its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  fell 1.14% to $6.05, Fortress Biotech Inc.  rose 0.98% to $3.09, and Viking Therapeutics Inc.  fell 3.92% to $37.48.Data source: Dow Jones Market Data, FactSet. Data compiled July 1, 2026.This content was created by M","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647430754","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2647430754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647430754?lang=en_us&edition=fundamental","pubTime":"2026-06-30 05:21","pubTimestamp":1782768060,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 2.75% to $8.98 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 2.07% to 25,820.14 and the Dow Jones Industrial Average  rising 0.59% to 52,182.74.This was the stock's third consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 56.32% below its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 2.16% to $6.14, Fortress Biotech Inc.  rose 6.88% to $2.95, and Viking Therapeutics Inc.  rose 3.94% to $39.54.Trading volume  remained 116,144 below its 50-day average volume of 532,950.Data source: Dow Jones Market D","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646360216","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2646360216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646360216?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:35","pubTimestamp":1782506100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. advanced 5.9% to $8.74 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 25,297.62 and Dow Jones Industrial Average falling 0.1% to 51,876.11.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 57.5% short of its 52-week high of $20.56, which the company reached on October 20th.The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 2.7% to $6.01, Fortress Biotech Inc. fell 8.6% to $2.76, and Viking Therapeutics Inc. rose 2.84% to $38.04.Trading volume totaled 2.4 million, compared to the 50-day average of 489,238.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 26, 2026 16:35 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645854434","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2645854434","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645854434?lang=en_us&edition=fundamental","pubTime":"2026-06-24 05:20","pubTimestamp":1782249600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 1.81% to $8.46 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.21% to 25,587.04 and Dow Jones Industrial Average  falling 0.09% to 51,666.84.This was the stock's fourth consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 58.85% short of its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 0.83% to $5.95, Fortress Biotech Inc.  rose 2.60% to $3.16, and Viking Therapeutics Inc.  rose 7.54% to $34.81.Trading volume  remained 209,006 below its 50-day average volume of 481,916.Data source: Dow Jones Market Data, FactSet. Data compiled June 23, 2026.This content was created by MarketWatch, which is oper","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645565778","title":"Corbus Pharmaceuticals price target lowered to $34 from $44 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2645565778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645565778?lang=en_us&edition=fundamental","pubTime":"2026-06-24 03:12","pubTimestamp":1782241948,"startTime":"0","endTime":"0","summary":"Mizuho analyst Graig Suvannavejh lowered the firm’s price target on Corbus Pharmaceuticals (CRBP) to $34 from $44 and keeps an Outperform rating on...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/corbus-pharmaceuticals-price-target-lowered-to-34-from-44-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/corbus-pharmaceuticals-price-target-lowered-to-34-from-44-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645267834","title":"Mizuho Securities Cuts Price Target on Corbus Pharmaceuticals to $34 From $44, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2645267834","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645267834?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:03","pubTimestamp":1782223427,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals (CRBP) has an average rating of buy and mean price target of $36.30, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MFG","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644316390","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2644316390","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644316390?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:22","pubTimestamp":1781817720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 2.61% to $8.26 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.91% to 26,517.93 and the Dow Jones Industrial Average  rising 0.14% to 51,564.70.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 59.82% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 2.68% to $5.80, Fortress Biotech Inc.  fell 2.61% to $2.99, and Viking Therapeutics Inc.  rose 0.30% to $30.38.Trading volume  remained 180,363 below its 50-day average volume of 478,122.Data source: Dow Jones Market Data, FactSet. Data compiled June 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644031007","title":"Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644031007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644031007?lang=en_us&edition=fundamental","pubTime":"2026-06-18 15:50","pubTimestamp":1781769052,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ascendis Pharma (ASND) and Corbus Pharmaceuticals (C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ASND","BK4581","BK4588","LU0109394709.USD","LU0889565916.HKD","XLV","LU0128526141.USD","HCSG","CRBP","BK4137","BK4139","XBI","LU0029874061.USD","LU0320765992.SGD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644724222","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2644724222","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644724222?lang=en_us&edition=fundamental","pubTime":"2026-06-18 05:19","pubTimestamp":1781731140,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 2.16% to $8.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.34% to 26,021.66 and Dow Jones Industrial Average  falling 0.98% to 51,492.55.Corbus Pharmaceuticals Holdings Inc. closed 60.85% below its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  rose 4.01% to $5.96, Fortress Biotech Inc.  rose 4.78% to $3.07, and Viking Therapeutics Inc.  rose 2.16% to $30.29.Trading volume  remained 198,629 below its 50-day average volume of 477,586.Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644595746","title":"Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $52 From $54, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2644595746","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644595746?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:31","pubTimestamp":1781699491,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Holdings (CRBP) has an average rating of buy and mean price target of $36.30, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","CRBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":-0.0189},{"period":"1month","weight":0.0638},{"period":"3month","weight":-0.135},{"period":"6month","weight":0.0126},{"period":"1year","weight":0.0161},{"period":"ytd","weight":0.086}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0041},{"period":"3month","weight":0.055},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.1885},{"period":"ytd","weight":0.096}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.363358},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.048678},{"month":3,"riseRate":0.636364,"avgChangeRate":0.197993},{"month":4,"riseRate":0.545455,"avgChangeRate":0.046477},{"month":5,"riseRate":0.583333,"avgChangeRate":0.055971},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.044414},{"month":7,"riseRate":0.25,"avgChangeRate":-0.050981},{"month":8,"riseRate":0.636364,"avgChangeRate":0.095672},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.086452},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.124298},{"month":11,"riseRate":0.727273,"avgChangeRate":0.130055},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.132264}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Corbus Pharmaceuticals,CRBP,Corbus Pharmaceuticals股票,Corbus Pharmaceuticals股票老虎,Corbus Pharmaceuticals股票老虎国际,Corbus Pharmaceuticals行情,Corbus Pharmaceuticals股票行情,Corbus Pharmaceuticals股价,Corbus Pharmaceuticals股市,Corbus Pharmaceuticals股票价格,Corbus Pharmaceuticals股票交易,Corbus Pharmaceuticals股票购买,Corbus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}